Role of toll-like receptor 13 in innate immune recognition of group B streptococci

Infection and Immunity

Volumn 82, Issue 12, 2014, Pages 5013-5022

  Signorino, Giacomo ^a   Mohammadi, Nastaran ^a   Patanè, Francesco ^a   Buscetta, Marco ^a   Venza, Mario ^a   Venza, Isabella ^a   Mancuso, Giuseppe ^a   Midiri, Angelina ^a   Alexopoulou, Lena ^b   Teti, Giuseppe ^a   Biondo, Carmelo ^a   Beninati, Concetta ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BACTERIAL RNA; CHAPERONE; CLINDAMYCIN; CYTOKINE; ERYTHROMYCIN; METHYLTRANSFERASE; NITROUS OXIDE; RIBOSOME RNA; RNA 23S; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 13; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BACTERIAL DNA; RIBOSOME DNA; TLR13 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL CELL; BACTERIAL IMMUNITY; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM CULTURE; BONE MARROW CELL; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE PREDISPOSITION; ENZYME INDUCTION; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HOST RESISTANCE; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; INFLAMMATION; INNATE IMMUNITY; LOSS OF FUNCTION MUTATION; MACROPHAGE CULTURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; RNA EXTRACTION; RNA PURIFICATION; STREPTOCOCCUS AGALACTIAE; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; CLUSTER ANALYSIS; DNA SEQUENCE; GENETICS; IMMUNOLOGY; MACROPHAGE; MOLECULAR GENETICS; PHYLOGENY;

ANIMALS; CELLS, CULTURED; CLUSTER ANALYSIS; DENDRITIC CELLS; DNA, BACTERIAL; DNA, RIBOSOMAL; IMMUNITY, INNATE; MACROPHAGES; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA; STREPTOCOCCUS AGALACTIAE; TOLL-LIKE RECEPTORS;

EID: 84911375546     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02282-14     Document Type: Article

References (33)

1. Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449:819-826. http://dx.doi.org/10.1038/nature06246.
2. Mancuso G, Gambuzza M, Midiri A, Biondo C, Papasergi S, Akira S, Teti G, Beninati C. 2009. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat. Immunol. 10:587-594. http://dx.doi.org/10.1038/ni.1733.
3. Biondo C, Mancuso G, Beninati C, Iaria C, Romeo O, Cascio A, Teti G. 2012. The role of endosomal Toll-like receptors in bacterial recognition. Eur. Rev. Med. Pharmacol. Sci. 16:1506-1512.
4. Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, Heath PT. 2012. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 379:547-556. http://dx.doi.org/10.1016/S0140-6736(11)61651-6.
5. Deutscher M, Lewis M, Zell ER, Taylor TH, Jr, Van Beneden C, Schrag S. 2011. Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin. Infect. Dis. 53:114-123. http://dx.doi.org/10.1093/cid/cir325.
6. Costa A, Gupta R, Signorino G, Malara A, Cardile F, Biondo C, Midiri A, Galbo R, Trieu-Cuot P, Papasergi S, Teti G, Henneke P, Mancuso G, Golenbock DT, Beninati C. 2012. Activation of the NLRP3 inflammasome by group B streptococci. J. Immunol. 188:1953-1960. http://dx.doi.org/10.4049/jimmunol.1102543.
7. Mancuso G, Midiri A, Biondo C, Beninati C, Zummo S, Galbo R, Tomasello F, Gambuzza M, Macri G, Ruggeri A, Leanderson T, Teti G. 2007. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J. Immunol. 178:3126-3133. http://dx.doi.org/10.4049/jimmunol.178.5.3126.
8. Mancuso G, Midiri A, Beninati C, Biondo C, Galbo R, Akira S, Henneke P, Golenbock D, Teti G. 2004. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease. J. Immunol. 172:6324-6329. http://dx.doi.org/10.4049/jimmunol.172.10.6324.
9. Henneke P, Morath S, Uematsu S, Weichert S, Pfitzenmaier M, Takeuchi O, Muller A, Poyart C, Akira S, Berner R, Teti G, Geyer A, Hartung T, Trieu-Cuot P, Kasper DL, Golenbock DT. 2005. Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J. Immunol. 174:6449-6455. http://dx.doi.org/10.4049/jimmunol.174.10.6449.
10. Deshmukh SD, Kremer B, Freudenberg M, Bauer S, Golenbock DT, Henneke P. 2011. Macrophages recognize streptococci through bacterial single-stranded RNA. EMBO Rep. 12:71-76. http://dx.doi.org/10.1038/embor.2010.189.
11. Lee BL, Moon JE, Shu JH, Yuan L, Newman ZR, Schekman R, Barton GM. 2013. UNC93B1 mediates differential trafficking of endosomal TLRs. eLife 2:e00291. http://dx.doi.org/10.7554/eLife.00291.
12. Hochrein H, Kirschning CJ. 2013. Bacteria evade immune recognition via TLR13 and binding of their 23S rRNA by MLS antibiotics by the same mechanisms. Oncoimmunology 2:e23141. http://dx.doi.org/10.4161/onci.23141.
13. Li XD, Chen ZJ. 2012. Sequence specific detection of bacterial 23S ribosomal RNA by TLR13. eLife 1:e00102. http://dx.doi.org/10.7554/eLife.00102.
14. Oldenburg M, Kruger A, Ferstl R, Kaufmann A, Nees G, Sigmund A, Bathke B, Lauterbach H, Suter M, Dreher S, Koedel U, Akira S, Kawai T, Buer J, Wagner H, Bauer S, Hochrein H, Kirschning CJ. 2012. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 337:1111-1115. http://dx.doi.org/10.1126/science.1220363.
15. Fernandez-Munoz R, Monro RE, Torres-Pinedo R, Vazquez D. 1971. Substrate-and antibiotic-binding sites at the peptidyl-transferase centre of Escherichia coli ribosomes. Studies on the chloramphenicol, lincomycin and erythromycin sites. Eur. J. Biochem. 23:185-193.
16. Lai CJ, Weisblum B. 1971. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 68:856-860. http://dx.doi.org/10.1073/pnas.68.4.856.
17. Papasergi S, Lanza Cariccio V, Pietrocola G, Domina M, D'Aliberti D, Trunfio MG, Signorino G, Peppoloni S, Biondo C, Mancuso G, Midiri A, Rindi S, Teti G, Speziale P, Felici F, Beninati C. 2013. Immunogenic properties of Streptococcus agalactiae FbsA fragments. PLoS One 8:e75266. http://dx.doi.org/10.1371/journal.pone.0075266.
18. Danne C, Guerillot R, Glaser P, Trieu-Cuot P, Dramsi S. 2013. Construction of isogenic mutants in Streptococcus gallolyticus based on the development of new mobilizable vectors. Res. Microbiol. 164:973-978. http://dx.doi.org/10.1016/j.resmic.2013.09.002.
19. Holo H, Nes IF. 1989. High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl. Environ. Microbiol. 55:3119-3123.
20. Biswas I, Gruss A, Ehrlich SD, Maguin E. 1993. High-efficiency gene inactivation and replacement system for gram-positive bacteria. J. Bacteriol. 175:3628-3635.
21. NCCLS. 2002. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. NCCLS document M100-S12. NCCLS, Wayne, PA.
22. Carey RB, Eisenstein TK, Shockman GD, Greber TF, Swenson RM. 1980. Soluble group-and type-specific antigens from type III group B Streptococcus. Infect. Immun. 28:195-203.
23. Mancuso G, Midiri A, Beninati C, Piraino G, Valenti A, Nicocia G, Teti D, Cook J, Teti G. 2002. Mitogen-activated protein kinases and NF-kappa B are involved in TNF-alpha responses to group B streptococci. J. Immunol. 169: 1401-1409. http://dx.doi.org/10.4049/jimmunol.169.3.1401.
24. Chen C, Okayama H. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
25. Demaria O, Pagni PP, Traub S, de Gassart A, Branzk N, Murphy AJ, Valenzuela DM, Yancopoulos GD, Flavell RA, Alexopoulou L. 2010. TLR8 deficiency leads to autoimmunity in mice. J. Clin. Invest. 120:3651-3662. http://dx.doi.org/10.1172/JCI42081.
26. Ding AH, Nathan CF, Stuehr DJ. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
27. Steward CD, Raney PM, Morrell AK, Williams PP, McDougal LK, Jevitt L, McGowan JE, Jr, Tenover FC. 2005. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus. J. Clin. Microbiol. 43:1716-1721. http://dx.doi.org/10.1128/JCM.43.4.1716-1721.2005.
28. Sakiniene E, Bremell T, Tarkowski A. 1997. Inhibition of nitric oxide synthase (NOS) aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin. Exp. Immunol. 110:370-377. http://dx.doi.org/10.1046/j.1365-2249.1997.4431456.x.
29. Sasaki S, Miura T, Nishikawa S, Yamada K, Hirasue M, Nakane A. 1998. Protective role of nitric oxide in Staphylococcus aureus infection in mice. Infect. Immun. 66:1017-1022.
30. Teti G, Mancuso G, Tomasello F. 1993. Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. Infect. Immun. 61:227-235.
31. Hidmark A, von Saint Paul A, Dalpke AH. 2012. Cutting edge: TLR13 is a receptor for bacterial RNA. J. Immunol. 189:2717-2721. http://dx.doi.org/10.4049/jimmunol.1200898.
32. D'Costa VM, King CE, Kalan L, Morar M, Sung WW, Schwarz C, Froese D, Zazula G, Calmels F, Debruyne R, Golding GB, Poinar HN, Wright GD. 2011. Antibiotic resistance is ancient. Nature 477:457-461. http://dx.doi.org/10.1038/nature10388.
33. Hughes VM, Datta N. 1983. Conjugative plasmids in bacteria of the 'preantibiotic' era. Nature 302:725-726. http://dx.doi.org/10.1038/302725a0.